Lung Cancer

SEP 9, 2026 · OBSERVATIONAL STUDY

TROP2 NMR Concordance Study

ClinicalTrials.gov

This is a registry record for a planned observational study with no results reported; it describes study design and protocol only, making it preliminary evidence documentation rather than evidence of efficacy or safety.

SEP 8, 2026 · OBSERVATIONAL STUDY

HTA of NIVATS Based on RWE

ClinicalTrials.gov

This is a completed observational registry study with real-world evidence design; no results are posted in this registry record, and the study aims to generate evidence rather than test a hypothesis against a control.

SEP 8, 2026 · INTERVENTIONAL STUDY

Leveraging the Emergency Department (LEAD) Study

ClinicalTrials.gov

This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial still in recruitment phase with no posted results; it will examine reach and preliminary effectiveness of a tailored lung screening intervention in an ED setting.

SEP 8, 2026 · OBSERVATIONAL STUDY

Understanding Rural Patient and Provide Preferences for Mobile Lung Cancer Screening Clinics

ClinicalTrials.gov

This is a registry record for a suspended observational study with no posted results; it describes planned methods and enrollment targets only, making it an early-stage implementation and feasibility project.

SEP 4, 2026 · OBSERVATIONAL STUDY

Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.

ClinicalTrials.gov

This is a registry record for a recruiting observational study with no results posted; it describes planned diagnostic methodology without outcome data, efficacy estimates, or comparisons to frozen section.

AUG 20, 2026 · OBSERVATIONAL STUDY

PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer

ClinicalTrials.gov

This is an observational registry study in recruitment with no reported results; it describes a planned comparison of checkpoint inhibitor rechallenge strategies in lung cancer patients with prior pneumonitis, addressing an important safety question but delivering no outcome data yet.

AUG 19, 2026 · PHASE 3 TRIAL

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

ClinicalTrials.gov

This is a Phase 3 registry record with no posted results; the study is actively recruiting and design details do not yet support efficacy or safety claims.

AUG 19, 2026 · PHASE 2 TRIAL

To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations

ClinicalTrials.gov

This is an active, ongoing Phase 2 trial registration with no results posted; the design and planned endpoints are reported but outcome data are not yet available.